Passage Bio (PASG)
US Market

Passage Bio (PASG) Financial Statements


Passage Bio Financial Overview

Passage Bio's market cap is currently ―. The company's EPS TTM is $-2.055; its P/E ratio is -0.31; Passage Bio is scheduled to report earnings on February 29, 2024, and the estimated EPS forecast is $-0.42. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue----$ 0.00
Gross Profit-----
EBIT$ -27.12M$ -23.86M$ -34.34M$ -28.24M$ -26.03M
EBITDA$ -26.54M$ -23.63M$ -33.44M$ -27.71M$ -25.10M
Net Income Common Stockholders$ -27.12M$ -23.86M$ -34.34M$ -27.07M$ -26.70M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 132.78M$ 151.48M$ 167.77M$ 189.61M$ 213.76M
Total Assets$ 169.26M$ 193.70M$ 213.24M$ 243.55M$ 270.05M
Total Debt$ 26.52M$ 26.74M$ 26.95M$ 27.11M$ 27.29M
Net Debt$ -106.26M$ -124.74M$ -140.82M$ -162.50M$ -186.47M
Total Liabilities$ 42.98M$ 43.28M$ 42.89M$ 42.18M$ 45.66M
Stockholders Equity$ 126.28M$ 150.41M$ 170.35M$ 201.37M$ 224.40M
Cash Flow-
Free Cash Flow$ -19.17M$ -17.18M$ -22.45M$ -24.50M$ -25.14M
Operating Cash Flow$ -19.16M$ -17.08M$ -22.42M$ -24.02M$ -23.39M
Investing Cash Flow$ 22.45M$ 13.97M$ 21.22M$ -3.36M$ -4.76M
Financing Cash Flow-$ 89.00K-$ -588.00K$ -408.00K
Currency in USD

Passage Bio Earnings and Revenue History

Passage Bio Debt to Assets

Passage Bio Cash Flow

Passage Bio Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis